INMi003-A

Registration Summary:

A P E C

CRX-CRD-iPSC

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg Name	INMi003-A
Alternative name(s)	CRX-CRD-iPSC
Cell line type	Human induced pluripotent stem cell (hiPSC)
Last update	8th March 2019
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	Institute for Neurosciences of Montpellier (INM)
External Databases
Cellosaurus	CVCL_WR01
Wikidata	Q94317998
General Information
Publications	Erkilic N et al. Generation of a human iPSC line, INMi003-A, with a missense mutation in CRX associated with autosomal dominant cone-rod dystrophy. Stem cell research. 2019 Jul;38:101478. Erkilic N et al. A Novel Chromosomal Translocation Identified due to Complex Genetic Instability in iPSC Generated for Choroideremia. Cells. 2019 Sep 11;8(9). Diakatou M et al. Allele-Specific Knockout by CRISPR/Cas to Treat Autosomal Dominant Retinitis Pigmentosa Caused by the G56R Mutation in NR2E3. International journal of molecular sciences. 2021 Mar 5;22(5). Pushp P et al. A Concise Review on Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Personalized Regenerative Medicine. Stem cell reviews and reports. 2021 Jun;17(3):748-776. Cui H et al. Various phenotypes of autosomal dominant cone-rod dystrophy with cone-rod homeobox mutation in two Chinese families. International journal of ophthalmology. 2022;15(12):1915-1923. Chien Y et al. Nanoparticles-mediated CRISPR-Cas9 gene therapy in inherited retinal diseases: applications, challenges, and emerging opportunities. Journal of nanobiotechnology. 2022 Dec 3;20(1):511.

hIPSC Derivation

General